CARLY RADCLIFFE: Open Payments
NPI 1003581463 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Janssen Biotech, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Fabhalta, RYBREVANT, LIBTAYO, TAVALISSE, Trodelvy, Nubeqa, ZYNLONTA, KEYTRUDA.
Industry payments across CT — which companies pay providers there.
